Jennifer Ku to Vaccination
This is a "connection" page, showing publications Jennifer Ku has written about Vaccination.
Connection Strength
0.935
-
Risk of Corneal Graft Rejection and Vaccination: A Matched Case-Control Study From a United States Integrated Health Care System. Am J Ophthalmol. 2024 07; 263:133-140.
Score: 0.624
-
Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022-2023 Influenza Season Among Adults =65 Years of Age. Clin Infect Dis. 2024 Nov 22; 79(5):1283-1292.
Score: 0.164
-
Comparative Effectiveness of Cell-Based Versus Egg-Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022-2023 Season Among Adults 18-64?Years. Influenza Other Respir Viruses. 2024 Dec; 18(12):e70025.
Score: 0.041
-
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Nat Commun. 2023 Jan 12; 14(1):189.
Score: 0.036
-
Risk of herpes zoster following mRNA COVID-19 vaccine administration. Expert Rev Vaccines. 2023 Jan-Dec; 22(1):643-649.
Score: 0.036
-
Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study. BMJ. 2021 12 15; 375:e068848.
Score: 0.033